Lucid Group
Lucid Group is a London-headquartered healthcare communications consultancy serving pharmaceutical, biotech, MedTech, and consumer health clients with strategy consulting, medical communications, and AI-enabled analytics across UK and US offices.
- Company typePrivate
- Founded2007
- HeadquartersLondon, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Lucid Group does
Lucid Group is a London-headquartered strategic healthcare communications consultancy founded in 2007, serving pharmaceutical, biotechnology, medical device, and consumer healthcare companies. The firm delivers an integrated portfolio spanning strategy consulting, scientific and medical communications, commercial communications, and digital/creative services, with approximately 500-600 specialists operating from four offices in the UK (London, Macclesfield, Manchester) and the US (Philadelphia). The company is privately held and backed by alternative asset manager Intermediate Capital Group (ICG), with founder Dennis O'Brien continuing as CEO and former Pfizer R&D leader Rod MacKenzie appointed Board Chair in 2026.
At the core of Lucid's offering is the proprietary Lucid Connected Intelligence (LCI) platform, which mines millions of patient healthcare interaction data points spanning diagnosis, prescription, procedure, demographic, and geographic information to support market definition, journey mapping, HCP behavior analysis, and campaign optimisation. AI-enabled solutions are positioned as 'woven in by design' across the asset lifecycle, supporting strategy refinement, content generation, and omnichannel activation. Lucid reports a 20+ year track record with 100+ product launches delivered across high-science therapeutic areas, with documented outcomes including 168% of sales target achievement for an oncology launch, 9x audience growth with doubled ROI to 5.6:1 for a multiple sclerosis brand, and 63% oncologist brand recognition within six months of launch.
Lucid monetises through project-based professional services engagements and retainer arrangements with enterprise life sciences clients, building bespoke teams per engagement. The firm has expanded through inorganic moves including the 2019 acquisition of HealthCare21, the 2021 acquisition of US-based DiD (strategic brand consultancy), and the 2023 acquisition of Synetic Life Sciences (life sciences management consulting). Lucid holds ISO 27001 certification (2025), EcoVadis Silver status placing it in the top 25% of rated companies, and United Nations Global Compact membership, signalling enterprise-grade security and ESG maturity valued by global pharma procurement.
Lucid Group firmographics
Firmographics- Name
- Lucid Group
- Legal name
- Lucid Group Communications Limited
- Website
- https://wearelucidgroup.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Lucid Group is a London-headquartered healthcare communications consultancy serving pharmaceutical, biotech, MedTech, and consumer health clients with strategy consulting, medical communications, and AI-enabled analytics across UK and US offices.
- Ownership category
- akta.pro rank
Lucid Group industry classification
Industry- Product category
- Healthcare Communications Consulting
- NAICS
- Advertising, Public Relations, and Related Services (5418), Management Consulting Services (54161), Marketing Consulting Services (541613)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Healthcare & Life Sciences PR (MPAAADAD)
Keywords
Where Lucid Group is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices5 records
Markets served
Lucid Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Strategic Consulting Services: Strategy consulting engagements for life sciences including clinical development, medical affairs, asset commercialisation, and HCP/patient engagement
- Scientific and Medical Communications: Strategic scientific and medical communications services with deep scientific and therapy area expertise supporting Global and US markets
- Commercial Communications: Commercial communications services including omnichannel programmes, creative development, and brand strategy execution
- Digital and Creative Services: Digital and creative consultancy services integrated with strategic communications for end-to-end healthcare marketing solutions
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Project-based consulting engagements for life sciences organisations |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Lucid Group product offering
Product offeringCore offering
Lucid Group is a global healthcare communications consultancy that helps pharmaceutical, biotech, and life sciences companies translate scientific evidence into stakeholder belief and commercial outcomes across the asset lifecycle. Its portfolio includes Strategy Consulting, Scientific and Medical Communications, Commercial Communications, and proprietary analytics through the Lucid Connected Intelligence (LCI) platform, supported by AI-Powered Solutions and acquired capabilities from DiD Agency and Synetic Life Sciences.
Product overview
Lucid Group is a global strategic healthcare communications consultancy offering an integrated portfolio of services. The core offering comprises Strategy Consulting (strategic solutions for life sciences spanning clinical development, medical affairs, and commercialisation), Scientific and Medical Communications (translating scientific insight into impactful narratives), Commercial Communications (omnichannel programmes and creative development), and AI-Powered Solutions (AI-enabled tools woven throughout all services). The proprietary Lucid Connected Intelligence (LCI) platform serves as the analytics engine powering data-driven insights across the portfolio. The company has expanded through strategic acquisitions including DiD Agency (US-based strategic brand consultancy with customer-centric marketing expertise) and Synetic Life Sciences (life sciences management consulting for operating model design and implementation).
Differentiator
Problem solved
Functional benefit
Brands
- Lucid Connected Intelligence (LCI): Proprietary business intelligence engine that mines patient healthcare interaction data for analytics and targeting
- AI-Powered Solutions
- DiD
- Synetic Life Sciences
- Lighthouse Medical Communications
Products and services
- Strategy Consulting Strategic consulting services for life sciences organisations spanning clinical development, medical affairs, asset commercialisation, and HCP/patient engagement, using data- and science-based approaches to help clients set direction and transform ideas into action across the product lifecycle.
- Scientific and Medical Communications Strategic scientific and medical communications services with deep therapy-area expertise supporting global and US markets, translating scientific insight into impactful strategies and compelling narratives that inspire behaviour change among HCPs and other stakeholders.
- Commercial Communications Commercial communications services including omnichannel programmes, creative development, media planning and activation, and digital content designed to drive clinical change, champion early adopters, and grow brand awareness for healthcare clients.
- Lucid Connected Intelligence (LCI) Proprietary advanced analytics platform that mines patient healthcare interaction data — including diagnosis, prescription, procedure, demographic, and geographic data — to identify patterns in patient populations, HCP behaviours, and market dynamics, enabling data-driven targeting, segmentation, and campaign optimisation for healthcare brands.
- AI-Powered Solutions AI-enabled solutions integrated with human insight, therapeutic depth, and behaviour-change expertise to amplify insight, accelerate execution, sharpen strategy, and drive lasting impact across the asset lifecycle.
- DiD Agency US-based strategic brand consultancy specialising in customer-centric marketing for life sciences, offering the 3-30/3-30 engagement framework for healthcare communications with expertise in market research, strategic insight development, and creative execution.
- Synetic Life Sciences Management consulting firm dedicated to life sciences, offering operating model design and implementation, strategic process and capability development, and support for planning and execution across the asset lifecycle.
Quantifiable outcome
- 168% of product sales target met within 6 months of launch for first systemic therapy in specialised oncology
- +4 more outcomes
Companies that use Lucid Group
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles5 records
Lucid Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Lucid Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Synetic Life SciencescoreLucid Group acquired Synetic Life Sciences, a management consulting firm dedicated to the life sciences industry. The acquisition provides clients with an end-to-end partnership across the development and commercialisation journey. Synetic supports clients with the design and implementation of operating models including building effective strategies, processes, capabilities, and organisational constructs.
- DiD (Design is Dead)coreLucid Group acquired the US-based strategic brand consultancy DiD to enhance its digital and healthcare services globally. The acquisition aims to strengthen Lucid's capabilities in addressing complex healthcare issues and expanding its market presence in the US.
Scale indicators6 records
Recent moves8 records
Expansion highlights6 records
Lucid Group competitors and assessment
Company assessmentDirect peers
- Real Chemistry: Independent healthcare communications and data analytics firm offering integrated strategy, creative, and data-driven marketing for life sciences clients. Highly comparable to Lucid in scope (medical communications, omnichannel activation, AI-enabled insights) and customer base (top pharma and biotech), positioning it as a primary direct peer.
- Inizio (formerly Ashfield): CD&R-backed global healthcare commercialisation platform offering medical communications, consulting, and patient solutions across the product lifecycle. Directly comparable as a PE-backed consolidator in the same healthcare communications and commercialisation space, with overlapping service lines (medical affairs, launch excellence, strategic consulting).
- Fishawack Health: PE-backed (Bridgepoint) healthcare communications group offering medical communications, consulting, and creative services to pharma clients. Directly comparable business model and customer base, with similar focus on launch support and scientific storytelling for life sciences brands.
Broad incumbents
- Publicis Health: Large network of healthcare communications agencies under Publicis Groupe offering advertising, PR, medical communications, and data services. Comparable to Lucid's commercial communications and medical affairs capabilities but at significantly greater scale with broader geographic reach and bundled holding company offerings.
- Omnicom Health Group: Network of healthcare-focused agencies under Omnicom providing advertising, branding, medical education, and consulting to pharma and biotech. Comparable service portfolio to Lucid with substantially larger scale, deeper media capabilities, and global procurement relationships with top pharma clients.
- IPG Health: Specialised healthcare communications network under Interpublic Group offering medical communications, brand strategy, and DTC advertising for pharma. Comparable to Lucid in therapeutic area depth and launch support but with broader network reach and deeper resources across creative and media.
- Havas Health & You: Global healthcare communications network under Havas offering creative, medical education, and patient engagement services. Comparable in serving pharma and biotech with launch and lifecycle communications, though larger and more diversified than Lucid's focused portfolio.
- McCann Health: Global healthcare communications network under IPG/McCann offering advertising, consulting, and medical communications for pharma clients. Comparable in serving top pharma with launch and brand strategy work, though it operates as part of a broader holding company structure.
Emerging players
- Syneos Health (now private under Elliott/Veritas): Clinical and commercial services organisation offering both CRO services and commercialisation/communications support for biopharma. Comparable in the commercial/launch support portion of its portfolio but with greater emphasis on clinical research and broader integrated offerings.
- ZS Associates: Global management consulting and professional services firm with significant pharma practice covering sales, marketing, and analytics strategy. Comparable to Lucid's strategy consulting and LCI analytics capabilities for life sciences clients, though more consulting-led than creative-led.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Lucid Group social profiles
Digital presenceLucid Group compliance and trust
Trust signalCompliance1 record
Lucid Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lucid Group leadership team
Management profileNumber of profiles
Profiles4 records
Lucid Group subsidiaries and ownership
Company hierarchySubsidiaries4 records
Lucid Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lucid Group M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lucid Group
What does Lucid Group do?
Lucid Group is a global healthcare communications consultancy that helps pharmaceutical, biotech, and life sciences companies translate scientific evidence into stakeholder belief and commercial outcomes across the asset lifecycle. Its portfolio includes Strategy Consulting, Scientific and Medical Communications, Commercial Communications, and proprietary analytics through the Lucid Connected Intelligence (LCI) platform, supported by AI-Powered Solutions and acquired capabilities from DiD Agency and Synetic Life Sciences.
Is Lucid Group a public or private company?
Lucid Group is a private company. It is classified as private equity controlled and is currently operating.
When was Lucid Group founded?
Lucid Group was founded in 2007. It employs 101 to 250 people.
Where is Lucid Group based?
Lucid Group is headquartered in London, United Kingdom, in the Europe region.
How does Lucid Group make money?
Four revenue lines are on record. Strategic Consulting Services are the primary driver. The others are scientific and Medical Communications, commercial Communications and digital and Creative Services.
Who are Lucid Group's main competitors?
Direct peers on record are Real Chemistry, Inizio (formerly Ashfield) and Fishawack Health. Broad incumbents are Publicis Health, Omnicom Health Group, IPG Health, Havas Health & You and McCann Health. Emerging players are Syneos Health (now private under Elliott/Veritas) and ZS Associates.
Does Lucid Group have an API?
No public API is recorded for Lucid Group.
What industry is Lucid Group in?
Lucid Group's product category is Healthcare Communications Consulting. Its primary akta.pro industry code is MPAAADAD, Healthcare & Life Sciences PR. Its NAICS code is 5418 and its SIC code is 8742.